Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zewei Wang

Showing results (111-120 of 158) with videos related to

Pageof 16
Sort By:
BMJ Oncology|January 31, 2025
Gender disparities in clinical outcomes of urothelial carcinoma linked to X chromosome gene <i>KDM6A</i> mutationZhaopei Liu, Kaifeng Jin, Ziyue Xu, et al.
Journal of Digital Imaging|June 6, 2022
Deep CTS: a Deep Neural Network for Identification MRI of Carpal Tunnel SyndromeHaiying Zhou, Qi Bai, Xianliang Hu, et al.
Bioelectrochemistry (Amsterdam, Netherlands)|January 15, 2023
New advances in treatment of skin malignant tumors with nanosecond pulsed electric field: A literature reviewHaiying Zhou, Zewei Wang, Yanzhao Dong, et al.
Cancer Medicine|March 8, 2024
POLQ identifies a better response subset to immunotherapy in muscle-invasive bladder cancer with high PD-L1Ge Liu, Kaifeng Jin, Zhaopei Liu, et al.
Cancer|December 10, 2025
Natural killer cell infiltration elicits gender-dependent dichotomous clinical outcomes in urothelial carcinomaLingkai Zhang, Zhaopei Liu, Yawei Ding, et al.
British Journal of Cancer|January 18, 2022
TIGIT and PD-1 expression atlas predicts response to adjuvant chemotherapy and PD-L1 blockade in muscle-invasive bladder cancerZhaopei Liu, Han Zeng, Kaifeng Jin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 11, 2025
ARID1A loss plus CD8+ T cell infiltration associate with favorable clinical outcomes in urothelial carcinomaZhaopei Liu, Lingkai Zhang, Kaifeng Jin, et al.
The Journal of Pathology|February 21, 2024
TP53 disruptive mutation predicts platinum-based chemotherapy and PD-1/PD-L1 blockade response in urothelial carcinomaKaifeng Jin, Jingtong Xu, Xiaohe Su, et al.
Cancer Immunology, Immunotherapy : CII|January 18, 2022
Immune inactivation by neuropilin-1 predicts clinical outcome and therapeutic benefit in muscle-invasive bladder cancerYanze Yu, Han Zeng, Kaifeng Jin, et al.
ACS Applied Materials & Interfaces|October 19, 2024
Plasma-Activated AVC Hydrogel for Reactive Oxygen and Nitrogen Species Delivery to Treat Allergic Contact DermatitisZijin Wu, Xixi Jing, Shenghang Xu, et al.
Pageof 16

Showing results (111-120 of 158) with videos related to

Sort By:
Pageof 16
BMJ Oncology|January 31, 2025
Gender disparities in clinical outcomes of urothelial carcinoma linked to X chromosome gene <i>KDM6A</i> mutationZhaopei Liu, Kaifeng Jin, Ziyue Xu, et al.
Journal of Digital Imaging|June 6, 2022
Deep CTS: a Deep Neural Network for Identification MRI of Carpal Tunnel SyndromeHaiying Zhou, Qi Bai, Xianliang Hu, et al.
Bioelectrochemistry (Amsterdam, Netherlands)|January 15, 2023
New advances in treatment of skin malignant tumors with nanosecond pulsed electric field: A literature reviewHaiying Zhou, Zewei Wang, Yanzhao Dong, et al.
Cancer Medicine|March 8, 2024
POLQ identifies a better response subset to immunotherapy in muscle-invasive bladder cancer with high PD-L1Ge Liu, Kaifeng Jin, Zhaopei Liu, et al.
Cancer|December 10, 2025
Natural killer cell infiltration elicits gender-dependent dichotomous clinical outcomes in urothelial carcinomaLingkai Zhang, Zhaopei Liu, Yawei Ding, et al.
British Journal of Cancer|January 18, 2022
TIGIT and PD-1 expression atlas predicts response to adjuvant chemotherapy and PD-L1 blockade in muscle-invasive bladder cancerZhaopei Liu, Han Zeng, Kaifeng Jin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 11, 2025
ARID1A loss plus CD8+ T cell infiltration associate with favorable clinical outcomes in urothelial carcinomaZhaopei Liu, Lingkai Zhang, Kaifeng Jin, et al.
The Journal of Pathology|February 21, 2024
TP53 disruptive mutation predicts platinum-based chemotherapy and PD-1/PD-L1 blockade response in urothelial carcinomaKaifeng Jin, Jingtong Xu, Xiaohe Su, et al.
Cancer Immunology, Immunotherapy : CII|January 18, 2022
Immune inactivation by neuropilin-1 predicts clinical outcome and therapeutic benefit in muscle-invasive bladder cancerYanze Yu, Han Zeng, Kaifeng Jin, et al.
ACS Applied Materials & Interfaces|October 19, 2024
Plasma-Activated AVC Hydrogel for Reactive Oxygen and Nitrogen Species Delivery to Treat Allergic Contact DermatitisZijin Wu, Xixi Jing, Shenghang Xu, et al.
Pageof 16